
US Launches Trade Investigation into German Drug Pricing
The US has initiated a trade probe into Germany's drug pricing policies, suspecting systematic underpayment for innovative medicines. Washington claims US patients bear a disproportionate R&D cost burden and warns of potential trade measures, including tariffs, if no resolution is reached.















